PRESCIENT THERAPEUTICS LIMITED

1.89%

5.2¢

Market Cap $41.87M

Healthcare Biotechnology

Prescient Therapeutics Limited is an Australia-based clinical-stage oncology company. The... Prescient Therapeutics Limited is an Australia-based clinical-stage oncology company. The Company is developing personalized medicine approaches to cancer, including targeted and cellular therapies. Its product pipeline includes PTX-100, PTX-200, OmniCAR, CellPryme-M and CellPryme-A. PTX-100 has completed Phase Ib expansion cohort study in relapsed and refractory T cell lymphomas. PTX-200 is a PH domain inhibitor that inhibits a tumor survival pathway, Akt. OmniCAR is a universal immune receptor platform being developed to enable controllable T-cell activity and multi-antigen targeting with a single-cell product. CellPryme-M technology enhances adoptive cell therapy performance by shifting T and NK cells towards a central memory phenotype, improving persistence, and increasing the ability to find and penetrate tumors. CellPryme-A is an adjuvant therapy designed to be administered to patients alongside cellular immunotherapy to help them overcome a suppressive tumor microenvironment.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Latest Threads

Tag

Subject

PTX

General information

13/06/25

24K

13/06/25

Last post Scottyhilux

24K

PTX

Ann: Change of Registered Office and Principal Place of Business

08/06/25

2.6K

08/06/25

Last post logan123

2.6K

PTX

Daily happenings?.

9 10 11

06/06/25

621

310K

06/06/25

Last post Biarra

621

310K

PTX

Ann: PTX Updated Investor Presentation

31/05/25

4.9K

31/05/25

Last post Shellbell

4.9K

PTX

Ann: First Patient dosed for PTX-100 Phase 2a Study

27/05/25

4.7K

27/05/25

Last post unitfree2

4.7K

PTX

Ann: Prescient Therapeutics - Investor Briefing

26/05/25

6.7K

26/05/25

Last post Vivo

6.7K

PTX

Ann: Prescient Therapeutics - Investor Briefing

24/05/25

6.6K

24/05/25

Last post Un1qu3Nam3

6.6K

PTX

Prescient Therapeutics Shareholder Update

21/05/25

1.0K

21/05/25

Last post Deanostock

1.0K

See All Discussions

Timeline

Change of Registered Office and Principal Place of Business
02 Jun 09:54	Share

PTX Updated Investor Presentation
29 May 11:00	Share

First Patient dosed for PTX-100 Phase 2a Study
27 May 09:07	Share

Prescient Therapeutics - Investor Briefing
21 May 11:19	Share

Change of Director's Interest Notice
06 May 13:22	Share

Change of Director's Interest Notice
02 May 12:28	Share

March 2025 Quarterly Update and Appendix 4C
28 Apr 10:00	Share

Prescient Therapeutics - Investor Briefing
17 Apr 12:04	Share

PTX-100 receives U.S. FDA Fast Track Designation
16 Apr 09:20	Share

Initial Director's Interest Notice
11 Apr 09:53	Share

PTX appoints Melanie Farris as Non-Executive Director
10 Apr 09:06	Share

Final Director's Interest Notice
01 Apr 11:13	Share

Prescient Therapeutics - Investor Briefing
31 Mar 09:58	Share

PTX Opens First Clinical site for PTX-100 Phase 2a Study
26 Mar 08:54	Share

Change of Chief Medical Officer
24 Mar 09:39	Share

PTX-100 clinical data presented at leading TCL meeting
21 Mar 09:58	Share

Change of Director's Interest Notice
17 Mar 09:09	Share

Change of Board Chair
11 Mar 09:52	Share

Appendix 4D and Half Year Financial Report
21 Feb 09:56	Share

December 2024 Quarterly Update and Appendix 4C - amended
31 Jan 15:00	Share

December 2024 Quarterly Update and Appendix 4C
31 Jan 09:55	Share

OmniCAR technical issues resolved and program to progress
23 Jan 09:47	Share

Final Director's Interest Notice
22 Jan 15:07	Share

Notification regarding unquoted securities - PTX
22 Jan 13:14	Share

Notification of cessation of securities - PTX
13 Jan 09:47	Share

US FDA allows PTX-100 Ph2 trial
23 Dec 09:26	Share

Appointment of Chief Executive Officer
17 Dec 11:52	Share

Change of Director's Interest Notice
11 Dec 16:14	Share

Notification regarding unquoted securities - PTX
11 Dec 16:13	Share

Change of Director's Interest Notices x4
04 Dec 16:15	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 5.2¢		Change -0.001(1.89%)		Mkt cap ! $41.87M

Open	High	Low	Value	Volume
5.3¢	5.3¢	4.9¢	$51.46K	1.024M

Buyers (Bids)

No.	Vol.	Price($)
1	18678	5.0¢

Sellers (Offers)

Price($)	Vol.	No.
5.2¢	50000	1

View Market Depth

No.	Vol.	Price($)
2	338000	0.049
3	643749	0.048
3	260659	0.047
2	130239	0.046
2	131111	0.045

Price($)	Vol.	No.
0.052	50000	1
0.053	50000	1
0.055	100000	1
0.056	57000	2
0.057	200000	1

Last trade - 15.15pm 13/06/2025 (20 minute delay)

PTX (ASX) Chart

PRESCIENT THERAPEUTICS LIMITED

Corporate Spotlight
Not Yet Available

Latest Threads

Timeline

Featured News

Latest Videos

FDA grants Prescient Therapeutics (ASX:PTX) broad orphan drug status for PTX-100 cancer treatment

09 Mar 2023 12:08 (AEDT)

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News

PRESCIENT THERAPEUTICS LIMITED

Corporate SpotlightNot Yet Available

Latest Threads

Timeline

Featured News

Latest Videos

FDA grants Prescient Therapeutics (ASX:PTX) broad orphan drug status for PTX-100 cancer treatment

09 Mar 2023 12:08 (AEDT)

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News

Corporate Spotlight
Not Yet Available